4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-021698
Chief Operations Officer sold 2,740 shares at $9.17 ($25,126)
From the SEC's structured data for this filing
Trades in this filing
Newell Joe · Chief Operations Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-27 | Sale : show line 1 in the form | −2,740 | $9.17 | $25,126 | 126,141 | D |
| Open-market sales · 2,740 sh · avg $9.17 · $25,126 | ||||||
Loading xslF345X03/doc4.xml…